• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Wiley Acquires Bio-Rad’s Informatics Spectroscopy Software and Spectral Databases

Share:

April 6, 2020

John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB), a global leader in research and education, today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics products including the company’s spectroscopy software and spectral databases. The acquisition adds expertise, content, and powerful software to Wiley’s Science Solutions segment. Terms of the agreement are not disclosed.

“Laboratory-generated data is at the heart of all research. We welcome these new spectroscopy products and services that will help enhance the Wiley Science Solutions portfolio,” said Judy Verses, Executive Vice President, Wiley Research. “These software and spectral libraries are invaluable interpretation tools for researchers who are making an impact in laboratories ranging from environmental to pharmaceutical, and from aerospace to toxicology.”

As one of the largest providers of spectral libraries in mass spectrometry and long-standing partner of Wiley, Bio-Rad’s Sadtler spectra databases in IR, Raman, UV-Vis and NMR allows Wiley to expand its offering in the spectroscopy market. With the acquisition of Bio-Rad’s KnowItAll desktop spectroscopy data system (SDS), server SDS, web-server SDS and ChemWindow chemical structure drawing software, Wiley is poised to enhance its support in vital areas of research data interpretation.

Wiley Science Solutions has been a trusted partner in publishing empirical, experimental, and validated data for laboratory solutions, aiming to improve the quality of chemical analysis and identification through spectral libraries and providing researchers with high-quality data collections to reduce errors and increase productivity in analytical, environmental, food, medicinal, and toxicology laboratories.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

This acquisition underscores Wiley’s commitment to investing in technology-based solutions that support the important research and development taking place in government, university and commercial labs around the world.

BIO-RAD, CHEMWINDOW, and KNOWITALL are trademarks of Bio-Rad Laboratories, Inc. in certain jurisdictions. All trademarks used herein are the property of their respective owner.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Arcadia Acquires Selected Assets of Massachusetts eHealth CollaborativeArcadia Acquires Selected Assets of Massachusetts eHealth Collaborative
  • DionyMed Brands Inc. Signs Binding Term Sheet to Acquire 1.83 Acre Southern California Cannabis Campus from MMACDionyMed Brands Inc. Signs Binding Term Sheet to Acquire 1.83 Acre Southern California Cannabis Campus from MMAC
  • High prices test private equity’s ability to close healthcare dealsHigh prices test private equity’s ability to close healthcare deals
  • TransformativeMed Expands Free COVID-19 EHR App To 10 Additional Health SystemsTransformativeMed Expands Free COVID-19 EHR App To 10 Additional Health Systems
  • HeavenlyRx to Acquire Industry-Leading CBD Brand PureKanaHeavenlyRx to Acquire Industry-Leading CBD Brand PureKana
  • Study: Physicians Found Use of Mobile Prenatal App Reduce in-Person Visits During PregnancyStudy: Physicians Found Use of Mobile Prenatal App Reduce in-Person Visits During Pregnancy
  • BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey.BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey.
  • Factory CRO and Boston Biomedical Associates Announce MergerFactory CRO and Boston Biomedical Associates Announce Merger

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications